Kimberly-Clark Corporation's international tissue business, valued at approximately $4 billion, has attracted final bids from Southeast Asia's Royal Golden Eagle (RGE), Asia Pulp & Paper Co (APP), and Brazil's Suzano SA. These companies are the final contenders in the acquisition process.
The bidders are currently conducting due diligence, with binding offers anticipated by mid-May. This development follows Kimberly-Clark's earlier announcement of a strategic review of its tissue operations outside North America.
The potential sale represents a significant step in Kimberly-Clark's strategy to optimize its portfolio. The transaction is being orchestrated by financial advisors Goldman Sachs and Centerview Partners.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.